title: Suppression of keratinocyte proliferation by plasminogen activator inhibitor-2.
abstract: We have previously shown that urokinase plasminogen activator (uPA) stimulates the growth of human keratinocytes in culture. For this effect, uPA activity is essential to generate the active amino terminal fragment, by an autolytic process. Our findings indicated further that inhibition of uPA may result in the suppression of growth of keratinoytes. Here, we provide evidence that plasminogen activator inhibitor (PAI)-2 has an anti-proliferative effect on keratinocytes. The uPA activity in cultured keratinocytes increased in parallel with cell proliferation, reaching a maximum level at confluency and decreasing gradually thereafter. The analysis of synchronized cells showed that the peak uPA activity in the medium occured just prior to S-phase, suggesting that the production and secretion of uPA is related to cell proliferation. In contrast, PAI-2 levels showed a steady increase, even after confluency. When PAI-2, purified from human cornified cells, was added to synchronized keratinocytes, S-phase was no longer evident and the peak uPA activity was eliminated. In experiments with a bacterially expressed PAI-2 fusion protein, [3H]thymidine incorporation by keratinocytes was significantly suppressed, confirming an anti-proliferative effect of PAI-2. These results strongly suggest that PAI-2 is involved in the regulation of keratinocyte proliferation and differentiation.
authors.affiliation: Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, USA.
authors.forename: T
authors.initials: T
authors.lastname: Hibino
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuda
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: P F
authors.initials: PF
authors.lastname: Goetinck
mesh_terms: D002455:Cell Division; D002478:Cells, Cultured; D006801:Humans; D015603:Keratinocytes / Q000502:physiology*; D017396:Plasminogen Activator Inhibitor 2 / Q000032:analysis / Q000494:pharmacology / Q000502:physiology*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000502:physiology
chemical_list: D017396:Plasminogen Activator Inhibitor 2; D011993:Recombinant Fusion Proteins; D014568:Urokinase-Type Plasminogen Activator; D013936:Thymidine